Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Syneos Health Inc (NQ: SYNH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Syneos Health Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Analyst Ratings for Syneos Health
Via Benzinga
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
Newly Established Network Will Enable High Quality DCTs & Digital Health Technology Solutions 
From Syneos Health, Inc.
Via GlobeNewswire
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
From Syneos Health, Inc.
Via GlobeNewswire
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Syneos Health's Earnings Outlook
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
Analyst Expectations for Syneos Health's Future
Via Benzinga
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
From Syneos Health, Inc.
Via GlobeNewswire
Expert Ratings for Syneos Health
Via Benzinga
Analyst Ratings for Syneos Health
Via Benzinga
Syneos Health Earnings Perspective: Return On Capital Employed
Via Benzinga
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Combined Capabilities Will Help Improve Trial Lifecycles for Patients, Sites & Sponsors 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions 
From Syneos Health, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023
Via Benzinga
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
Despite Uncertainties, Survey Hints that Dealmaking Intensity Could Be Poised for a Rebound After a Year of Inertia 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Announces Chief Financial Officer Transition
Reaffirms Full-Year 2022 Revenue Guidance 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Extends Partnership with Medable
Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient 
From Syneos Health, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Syneos Health Releases 2023 Health Trends
Predicts AI and Machine Learning, Diversity and Medical Affairs will Transform Biopharma Product Development 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
From Syneos Health, Inc.
Via GlobeNewswire
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Expert Ratings for Syneos Health
Over the past 3 months, 11 analysts have published their opinion on Syneos Health (NASDAQ:SYNH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Dow Rises 100 Points; Silver Jumps 7%
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining over 100 points on Friday. 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.